Ipsen – Consolidated Financial Statements – 2022

Corporate 24 April 2024 7 mins read

Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance

Corporate 08 February 2024 8 mins read

Building on solid FY 2023 results, Ipsen anticipates four launches in 2024

Corporate 26 October 2023 7 mins read

Ipsen delivers solid sales growth in the first nine months of 2023 and confirms its full-year guidance

Corporate 27 July 2023 5 mins read

Ipsen delivers solid H1 2023 results and upgrades its full-year guidance

Corporate 27 April 2023 4 mins read

Ipsen delivers robust sales growth in the first quarter of 2023 and confirms its full-year guidance

Corporate 09 February 2023 7 mins read

Ipsen presents strong full-year 2022 results and guidance for 2023

Corporate 27 October 2022 4 mins read

Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance

Corporate 28 July 2022 6 mins read

Ipsen delivers strong H1 2022 results and upgrades its full-year guidance

Corporate 27 April 2022 3 mins read

Ipsen delivers a strong sales performance in the first quarter of 2022

Corporate 11 February 2022 6 mins read

Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business